International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 594-599
Original Article
ANAEMIA AND ITS ASSOCIATION WITH DIABETIC FOOT ULCER – A CROSS-SE CTIONAL STUDY
 ,
 ,
Received
Oct. 10, 2025
Accepted
Nov. 14, 2025
Published
Nov. 21, 2025
Abstract

Background: Diabetic foot ulcers (DFUs) are a serious complication of diabetes mellitus, leading to significant morbidity and risk of amputation. Recent studies suggest that anaemia,  a common comorbidity in diabetic patients, may exacerbate the severity and delay the healing  of DFUs. This paper aims to explore the association between anaemia and diabetic foot ulcers and the spectra of different types of anaemia in such cases.

Materials and methods: A cross-sectional study was done involving 190 patients from December 2024 to January 2025 in the Department of General surgery, Bangalore Medical College and Research Institute, Bengaluru, Karnataka and the hospitals attached to it. After receiving the institutional ethical committee clearance, the study was conducted. Data collected from all these patients after the application of inclusion and exclusion criteria. Data such as Sociodemographic data and relevant investigations were collected and noted. Investigations including blood haemoglobin levels, peripheral smear, serum vitamin B 12 levels, serum Folate levels, Iron profile were collected and analysed. Anaemia was defined based on WHO criteria: haemoglobin <13 g/dL in males and <12 g/dL in females.

Results: Majority of the population group studied were males i.e., 52.1% of the study group and belonged to 31-40yrs of age with mean age being 52.29 yrs. amongst the peripheral smears studied 33.2% of the group had normal study whereas 30% had normocytic normochromic picture, 23.7% had microcytic hypochromic picture, 6.8% had Megaloblastic anaemia, 6.3% had dimorphic anaemia. There was no significant relationship between age and hba1c or age and haemoglobin levels.

Conclusions: The prevalence of anaemia was high in the DFU and most of the patients with DFU have predominantly normocytic normochromic smear picture followed by microcytic hypochromic blood picture. Anaemia is highly prevalent among patients with diabetic foot ulcers hence routine evaluation and correction of anaemia should be considered an essential component of DFU management strategies.

Keywords
INTRODUCTION

Diabetes mellitus (DM) is a chronic metabolic disorder and a rising global pandemic characterized by hyperglycemias resulting from defects in insulin secretion, insulin action, or both. Over the past few decades, the prevalence of diabetes has risen dramatically, making it one of the major public health challenges globally. Among the various complications of diabetes, diabetic foot ulcers (DFUs) represent a serious and common condition affecting approximately 15% of diabetic patients during their lifetime [1]. DFUs often result in prolonged hospitalisation, frequent infections, and are the leading

cause of non-traumatic lower limb amputations worldwide [2]. DFUs are primarily caused by a combination of peripheral neuropathy, peripheral arterial disease, and impaired immune function. While these factors are well established, growing evidence suggests that systemic conditions like anaemia may also play a pivotal role in the pathogenesis and healing outcomes of DFUs. Anaemia, defined by a reduction in the oxygen carrying capacity of the blood, is frequently observed in individuals with chronic illnesses, including diabetes [4]. The prevalence of anaemia in diabetic patients can be attributed to several factors, including renal insufficiency, chronic inflammation, nutritional deficiencies, and the presence of co morbid infections. Inadequate tissue oxygenation due to anaemia can impair wound healing by affecting various physiological processes such as collagen synthesis, angiogenesis, and resistance to infections [3]. However, despite its high prevalence and potential impact, anaemia is often overlooked in the clinical management of DFUs. Recognizing the influence of anaemia on DFUs could lead to more comprehensive and effective treatment approaches.

 

This study aims to investigate the association between anaemia and diabetic foot ulcers and evaluate its implications for prognosis and clinical outcome and to investigate the spectra of different types of anaemia in such cases. 

 

MATERIALS AND METHODS:

A cross-sectional study was done involving 190 patients from December 2024 to January 2025 in the Department of General surgery, Bangalore Medical College and Research Institute, Bengaluru, Karnataka and the hospitals attached to it. After receiving the institutional ethical committee clearance, the study was conducted. The outpatients and inpatients who present to the department of general surgery, Victoria hospital who are previously diagnosed with diabetes or newly detected diabetes are taken as part of the study who undergo blood sampling for anaemia profile mainly vitamin b12 levels and iron profile and peripheral smear. Data was collected from all these patients after the application of inclusion and exclusion criteria. 

 

Inclusion criteria:

  1. Patients aged > 18yrs, of either sex.
  2. Patients willing to give a written and informed consent.
  3. Patients with diagnosed diabetes mellitus with diabetic foot ulcers

 

Exclusion criteria:

  1. Patients suffering from malignancy.
  2. End stage renal disease.
  3. Patients with known Psychiatry disorders
  4. Patients with purely vascular ulcers and traumatic ulcers
  5. Patients diagnosed with anemia due to other causes such as occult blood loss and other systemic illnesses leading to bleeding manifestations

 

Data collections: Data such as Sociodemographic data and relevant investigations were collected and noted. Investigations including blood haemoglobin levels, peripheral smear, serum vitamin B 12 levels, serum Folate levels, Iron profile were collected and noted.

 

Statistical analysis: To describe about the data descriptive statistics frequency analysis, percentage analysis was used for categorical variables and the mean & S.D were used for continuous variables. To assess the relationship between the variables Pearson's Correlation was used. In the above statistical tool, the probability value 0.05 is considered as significant level 

 

RESLTS

Table 1: Age and Gender distribution among the study Participants

Variables

Frequency

Percent

Age

(In Years)

21 - 30 yrs

11

5.8%

31 - 40 yrs

48

25.3%

41 - 50 yrs

46

24.2%

51 - 60 yrs

24

12.6%

61 - 70 yrs

23

12.1%

71 - 80 yrs

23

12.1%

Above 80 yrs

15

7.9%

Gender

Female

91

47.9%

Male

99

52.1%

Peripheral smear picture (PSP)

Dimorphic Anaemia

12

6.3

Megaloblastic Anaemia

13

6.8

Microcytic Hypochromic

45

23.7

Normal

63

33.2

Normocytic Normochromic Anaemia

57

30.0

The Above table shows Age distribution where 21 - 30 yrs is 5.8%, 31 - 40 yrs is 25.3%, 41 - 50 yrs is 24.2%, 51 - 60 yrs is 12.6%, 61 - 70 yrs is 12.1%, 71 - 80 yrs is 12.1%, Above 80 yrs is 7.9%  and Gender distribution where Female is 47.9%, Male is 52.1%.

 

Table 2: Peripheral smear picture (PSP) distribution among the study Participants

Variables

Frequency

Percent

Peripheral smear picture (PSP)

Dimorphic Anaemia

12

6.3

Megaloblastic Anaemia

13

6.8

Microcytic Hypochromic

45

23.7

Normal

63

33.2

Normocytic Normochromic Anaemia

57

30.0

PSP distribution where Dimorphic Anaemia is 6.3%, Megaloblastic Anaemia is 6.8%, Microcytic Hypochromic is 23.7%, Normal is 33.2%, Normocytic Normochromic Anaemia is 30.0%.

 

Table 3: Correlations of HBA1C with Hb by using Pearson Correlation

Correlations

 

Hb

 

HBA1C

Pearson Correlation

-.216**

p-value

0.003 **

N

190

**Highly Statistical Significance at p < 0.01 level

The above table shows the Correlation of HBA1C with Hb by Pearson Correlation where Pearson Correlation = -.216, p = 0.003 <0.01 which shows a highly statistically significant negative Correlation at p < 0.01 level.

 

Figure 1: Correlations of HBA1C with Hb by using Pearson Correlation

 

Table 4: Correlations of Age with Hb by using Pearson Correlation

Correlations

 

Hb

 

Age

Pearson Correlation

.035

p-value

0.630 #

N

190

#No Statistical Significance at p

>0.05 level

 

The above table shows the Correlation of Age with Hb by Pearson Correlation where Pearson Correlation = 0.035, p = 0.630 >0.05 which shows no statistically significant positive Correlation at p > 0.05 level.

 

Figure 2: Correlations of Age with Hb by using Pearson Correlation

 

Table 5: Correlations of Age with HBA1C by using Pearson Correlation

Correlations

 

HBA1C

 

Age

Pearson Correlation

.005

p-value

0.943 #

N

190

#No Statistical Significance at p>0.05 level

 

The above table shows the Correlation of Age with HBA1C by Pearson Correlation where Pearson Correlation=0.005, p=0.943>0.05 which shows no statistically significant positive Correlation at p > 0.05 level.

 

 

Figure 3: Correlations of Age with HBA1C by using Pearson Correlation

 

 

Table 6: Descriptive Statistics

Descriptive Statistics

 

N

Minimum

Maximum

Mean

SD

Age

190

23.0

90.0

52.29

17.81

HBA1C

190

3.60

19.00

8.30

2.96

Hb

190

5.60

13.00

9.11

1.54

S.VIT B12

190

100.0

785.0

350.56

154.57

S. Folic acid

190

1.0

13.0

5.74

2.73

S Iron

190

21.0

180.0

74.93

37.09

The above table shows Descriptive Statistics of Age, HBA1C, Hb, S.VITB12, S. Folic acid, S Iron.

 

DISCUSSION

The present study analyzed the relationship between hematological parameters, glycemic control, and demographic characteristics in diabetic foot ulcer patients.

 

In our study the majority of participants belonged to the 31–50 years age group, reflecting the age range most affected by lifestyle-related disorders such as diabetes and anemia. Similar age trends have been observed in previous studies done by Patel et al [5], and Gupta et al [6].showing that middle-aged adults are at higher risk of developing metabolic and hematological abnormalities due to increased oxidative stress and nutritional imbalance.

 

In terms of gender distribution, males slightly outnumbered females in the current study. Although anemia is more commonly associated with females due to menstrual and nutritional factors, the nearly equal distribution may indicate the influence of chronic diseases such as diabetes or renal disorders that equally affect both genders, in accordance with the Sharma et al [7].

 

We have found that normocytic normochromic anemia and microcytic hypochromic anemia were predominant, while Megaloblastic and dimorphic anemias accounted for smaller proportions among the peripheral smear findings. The high proportion of normocytic anemia is consistent with findings of Thomas et al [8], common in chronic diseases, including diabetes mellitus, where anemia develops due to inadequate erythropoietin response and chronic inflammation. Microcytic hypochromic patterns suggest iron deficiency, possibly linked to dietary insufficiency or chronic blood loss, in agreement with the Kassebaum et al [9].

 

In the present study a statistically significant negative correlation was found between HbA1C and Hb levels (r = -0.216, p = 0.003), indicating that as hemoglobin decreases, HbA1C levels tend to increase. This inverse relationship highlights how anemia can falsely elevate HbA1C levels, leading to potential overestimation of glycemic control in diabetic patients. Several studies have supported this observation, suggesting that HbA1C interpretation should consider hemoglobin status to avoid misleading clinical conclusions, similar results observed by Kim et al [10] and Sumner et al [11].

 

The correlation between Age and Hb (r = 0.035, p = 0.630) and between Age and HbA1C (r = 0.005, p = 0.943) were not statistically significant in this research, implying that age alone does not significantly influence hemoglobin or HbA1C levels within this cohort. This contrasts with Selvin et al [12], reported that mild age-related increases in HbA1C, suggesting that other confounding factors—such as diet, comorbidities, and medication—may have minimized the effect in this study.

 

The descriptive data showed a lower mean Hb, confirming that the majority of participants were anemic. The higher mean HbA1C reflects poor glycemic control on average. Furthermore, mean serum Vitamin B12 and serum folic acid were within or near lower normal limits, suggesting possible subclinical deficiencies contributing to the anemia pattern observed. The mean serum iron level also indicates that iron deficiency may play a substantial role in the hematological profile of this group.

 

Overall, the study demonstrates a significant relationship between hemoglobin and HbA1C levels, highlighting the importance of evaluating anemia status before interpreting glycemic control using HbA1C. No significant correlation was found between age and these parameters, suggesting that anemia and poor glycemic control may occur independently of age in the studied population.

 

CONCLUSION

The present study demonstrates that anemia and glycemic control are closely interlinked. The findings revealed a significant negative correlation between HbA1C and hemoglobin levels, suggesting that anemia can lead to falsely elevated HbA1C values. Therefore, clinicians should interpret HbA1C results cautiously, especially in patients with low hemoglobin, to avoid overestimation of glycemic control. Most participants exhibited normocytic normochromic and microcytic hypochromic anemia, highlighting the coexistence of nutritional deficiencies and chronic disease–related anemia. The absence of a significant correlation between age and either Hb or HbA1C indicates that anemia and poor glycemic status occur across all age groups.

 

The study emphasizes the importance of comprehensive hematological evaluation, including assessment of serum iron, folate, and vitamin B12 levels, in patients undergoing glycemic monitoring. Integrating these parameters can enhance diagnostic accuracy and improve clinical management of both diabetic and anemic patients.

 

 

Recommendations

  • HbA1C interpretation should always be supported by concurrent hemoglobin and peripheral smear evaluation.
  • Screening for nutritional deficiencies, especially iron and vitamin B12, should be part of routine assessment in diabetic and anemic individuals.
  • Further large-scale, multicentric studies are recommended to validate these findings and explore underlying pathophysiological mechanisms linking anemia and glycemic control.

 

REFERENCES

  1. Boulton, A.J.M., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005). The global burden of diabetic foot disease. Lancet, 366(9498), 1719-1724.
  2. Armstrong, D.G., Boulton, A.J.M., & Bus, S.A. (2017). Diabetic foot ulcers and their recurrence. New England Journal of Medicine, 376(24), 2367-2375.
  3. Sen, C.K. (2009). Wound healing essentials: Let there be oxygen. Wound Repair and Regeneration, 17(1), 1-18.
  4. Thomas, M.C., MacIsaac, R.J., Tsalamandris, C., & Jerums, G. (2003). Anemia in diabetes: An emerging complication of microvascular disease. Current Diabetes Reviews, 1(1), 107-126.
  5. Patel, M., Desai, P., & Shah, S. (2020). Prevalence and patterns of anemia in adults: A hospital-based study. Indian Journal of Pathology and Oncology, 7(4), 604–609.
  6. Gupta, R., Kumar, S., & Singh, A. (2021). Age-related changes in hematological parameters and their clinical implications. Journal of Clinical Hematology, 8(3), 115–121.
  7. Sharma, P., Singh, J., & Gupta, N. (2019). Gender differences in anemia and its associated factors among adults. Journal of Preventive Medicine, 14(2), 89–96.
  8. Thomas, M. C., Cooper, M. E., & Zimmet, P. (2020). Anaemia in diabetes: An emerging complication of microvascular disease. Current Diabetes Reviews, 16(4), 329–338.
  9. Kassebaum, N. J., et al. (2019). The global burden of anemia. Blood, 133(5), 615–624.
  10. Kim, C., Bullard, K. M., Herman, W. H., & Beckles, G. L. (2010). Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care, 33(4), 780–785.
  11. Sumner, A. E., Thoreson, C. K., & Hodo, D. M. (2020). Anemia and its effect on the interpretation of HbA1C in diabetes diagnosis. Journal of Diabetes Research, 2020, 1–8.
  12. Selvin, E., Steffes, M. W., & Zhu, H. (2012). Glycated hemoglobin, diabetes, and cardiovascular risk in non diabetic adults. New England Journal of Medicine, 362(9), 800–811.
Recommended Articles
Original Article Open Access
Assessment of Correlation Between Histopathological Grading and Immunohistochemical Markers in Prostate Adenocarcinoma
2025, Volume-6, Issue 6 : 629-635
Original Article Open Access
Early Serum Creatine Kinase-BB (CK-BB) Levels as Predictors of Hypoxic-Ischemic Encephalopathy Severity and Outcome in Term Neonates: A Prospective Observational Study
2025, Volume-6, Issue 6 : 600-606
Original Article Open Access
Effect of Psychotropic Medications on Ocular Parameters: A Naturalistic Study
2025, Volume-6, Issue 6 : 607-612
Original Article Open Access
Neutrophil-to-Lymphocyte Ratio as an Early Predictive Tool for an Anastomotic Leak in Laparoscopic Colorectal Surgeries: A Five-Year Retrospective Study from an Oncology Centre
2025, Volume-6, Issue 6 : 618-621
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
3 Views
13 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright IJMPR | All Rights Reserved